Cannabiz responds to rescheduling report

The cannabis world responded to a Washington Post report that President Trump plans reschedule the plant along familiar lines, with some praising the move and others calling it an inadequate halfway measure.

While there's widespread agreement that moving marijuana from schedule I to less restrictive schedule III would end industry-hated tax provision 280E's hold on the cannabiz, the other implications are not as clear. Current schedule III substances include ketamine, steroids and testosterone.

Here are a comments from two prominent industry insiders:

“This monumental change will have . . .

Log in or become a WeedWeek Member to read this article.